BAFF, APRIL and their receptors: structure, function and signaling - PubMed (original) (raw)
Review
BAFF, APRIL and their receptors: structure, function and signaling
Claudia Bossen et al. Semin Immunol. 2006 Oct.
Abstract
BAFF, APRIL and their receptors play important immunological roles, especially in the B cell arm of the immune system. A number of splice isoforms have been described for both ligands and receptors in this subfamily, some of which are conserved between mouse and human, while others are species-specific. Structural and mutational analyses have revealed key determinants of receptor-ligand specificity. BAFF-R has a strong selectivity for BAFF; BCMA has a higher affinity for APRIL than for BAFF, while TACI binds both ligands equally well. The molecular signaling events downstream of BAFF-R, BCMA and TACI are still incompletely characterized. Survival appears to be mediated by upregulation of Bcl-2 family members through NF-kappaB activation, degradation of the pro-apototic Bim protein, and control of subcellular localization of PCKdelta. Very little is known about other signaling events associated with receptor engagement by BAFF and APRIL that lead for example to B cell activation or to CD40L-independent Ig switch.
Comment in
- Travelling with the BAFF/BLyS family: are we there yet?
Mackay F, Cancro MP. Mackay F, et al. Semin Immunol. 2006 Oct;18(5):261-2. doi: 10.1016/j.smim.2006.07.003. Epub 2006 Aug 14. Semin Immunol. 2006. PMID: 16905331 No abstract available.
Similar articles
- Travelling with the BAFF/BLyS family: are we there yet?
Mackay F, Cancro MP. Mackay F, et al. Semin Immunol. 2006 Oct;18(5):261-2. doi: 10.1016/j.smim.2006.07.003. Epub 2006 Aug 14. Semin Immunol. 2006. PMID: 16905331 No abstract available. - BLyS and B cell homeostasis.
Woodland RT, Schmidt MR, Thompson CB. Woodland RT, et al. Semin Immunol. 2006 Oct;18(5):318-26. doi: 10.1016/j.smim.2006.06.001. Epub 2006 Aug 22. Semin Immunol. 2006. PMID: 16931037 Review. - Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M. Katsenelson N, et al. Eur J Immunol. 2007 Jul;37(7):1785-95. doi: 10.1002/eji.200636800. Eur J Immunol. 2007. PMID: 17557373 - The role of the BAFF/APRIL system on T cell function.
Mackay F, Leung H. Mackay F, et al. Semin Immunol. 2006 Oct;18(5):284-9. doi: 10.1016/j.smim.2006.04.005. Epub 2006 Aug 22. Semin Immunol. 2006. PMID: 16931039 Review. - Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A. Day ES, et al. Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k. Biochemistry. 2005. PMID: 15697217
Cited by
- Virulence and Immune Evasion Strategies of FMDV: Implications for Vaccine Design.
Medina GN, Diaz San Segundo F. Medina GN, et al. Vaccines (Basel). 2024 Sep 19;12(9):1071. doi: 10.3390/vaccines12091071. Vaccines (Basel). 2024. PMID: 39340101 Free PMC article. Review. - Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
Eslami M, Schuepbach-Mallepell S, Diana D, Willen L, Kowalczyk-Quintas C, Desponds C, Peter B, Vigolo M, Renevey F, Donzé O, Luther SA, Yalkinoglu Ö, Alouche N, Schneider P. Eslami M, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2404309121. doi: 10.1073/pnas.2404309121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990948 - Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study.
Fan C, Yang T, Zheng S, Liao X, Xie R, Chen S, Li J. Fan C, et al. Front Immunol. 2024 Jun 14;15:1423035. doi: 10.3389/fimmu.2024.1423035. eCollection 2024. Front Immunol. 2024. PMID: 38947321 Free PMC article. - Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease.
O'Brien JW, Case A, Kemper C, Zhao TX, Mallat Z. O'Brien JW, et al. Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1512-1522. doi: 10.1161/ATVBAHA.124.319844. Epub 2024 May 30. Arterioscler Thromb Vasc Biol. 2024. PMID: 38813699 Free PMC article. Review. - A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
Yin J, Zhao M, Xu X, Zhang M, Xu Z, Li Z, Qin X, Li Z, Zhao C, Zhou H, Ma Y, Cao W, Wang G, Lin Y, Zhang J, Zhang X, Cai H, Qian W, Wang Y, Zhang X, Liu G, Wang J, Qiu W, Min L, Li J, Deng H, Chu L, Zhang Y, Fang J. Yin J, et al. Eur J Neurol. 2024 Aug;31(8):e16322. doi: 10.1111/ene.16322. Epub 2024 May 10. Eur J Neurol. 2024. PMID: 38726639 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous